Novo Nordisk A/S (NVO) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET
Company Participants
Daniel Bohsen - Head of Investor Relations
Lars Fruergaard Jorgensen - President and Chief Executive Officer
Camilla Sylvest - Executive Vice President, Commercial Strategy and Corporate Affairs
Doug Langa - Executive Vice President, North America Operations
Martin Holst Lange - Executive Vice President, Development
Karsten Munk Knudsen - Executive Vice President and Chief Financial Officer
Conference Call Participants
Michael Nedelcovych - TD Cowen
Richard Parkes - BNP Paribas
Seamus Fernandez - Guggenheim Securities
Peter Verdult - Citigroup
Mark Purcell - Morgan Stanley
Emily Field - Barclays
Simon Baker - Redburn
Naresh Chouhan - Intron Health
Florent Cespedes - Societe Generale
Richard Vosser - JPMorgan
Peter Welford - Jefferies
Mattias Haggblom - Handelsbanken
Emmanuel Papadakis - Deutsche Bank
Michael Novod - Nordea
Operator
Good day and thank you for standing by. Welcome to the Q3 2023 Novo Nordisk A/S Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]
Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today Daniel Bohsen, Head of Investor Relations. Please go ahead, sir.
Daniel Bohsen
Welcome to this Novo Nordisk Earnings Call for the first nine months of 2023. This call follows the early announcement of top line results and the updated outlook for 2023 shared in October. The release was advanced due to Danish securities regulations.
My name is Daniel Bohsen and I'm the Head of Investor Relations at Novo Nordisk. With me today I have CEO of Novo Nordisk, Lars Fruergaard Jorgensen; Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; Executive Vice President and Head of Development, Martin Holst Lange; and finally Chief Financial Officer, Karsten Munk Knudsen.
All speakers will be available for the Q&A session. Today's announcement and the slides for this call are available on our website, novonordisk.com. Please note that this call is being webcast live and a recording will be made available on our website as well. The call is scheduled for one hour. Please turn to slide.
The presentation is structured as outlined on slide two. Please note that all sales and operating profit growth statements will be at constant exchange rates unless otherwise specified. Please turn to the next slide.